Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ANGION BIOMEDICA CORP.

(ANGN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Angion Biomedica : HC Wainwright & Co. Initiates Coverage on Angion Biomedica at Buy Rating, Sets Price Target at $100

03/01/2021 | 09:23am EST


© MT Newswires 2021
All news about ANGION BIOMEDICA CORP.
11/12Angion Provides Corporate Update and Reports Third Quarter 2021 Financial Results - For..
PU
11/12ANGION BIOMEDICA CORP. Management's Discussion and Analysis of Financial Condition and..
AQ
11/12Angion Biomedica Corp. Reports Earnings Results for the Third Quarter and Nine Months E..
CI
11/12Earnings Flash (ANGN) ANGION BIOMEDICA Reports Q3 Loss $-0.53
MT
11/12Earnings Flash (ANGN) ANGION BIOMEDICA Reports Q3 Revenue $1.5M
MT
11/12Angion Provides Corporate Update and Reports Third Quarter 2021 Financial Results
AQ
11/09HC Wainwright Adjusts Angion Biomedica's Price Target to $50 From $100, Reiterates Buy ..
MT
11/04Angion Presents Multiple Posters on ANG-3070 at Kidney Week 2021, Including Preclinical..
AQ
11/02Angion to Participate in Upcoming Investment Conference
AQ
10/27Top Midday Decliners
MT
More news
Analyst Recommendations on ANGION BIOMEDICA CORP.
More recommendations
Financials (USD)
Sales 2021 4,12 M - -
Net income 2021 - - -
Net Debt 2021 - - -
P/E ratio 2021 -
Yield 2021 -
Capitalization 108 M 108 M -
Capi. / Sales 2021 26,2x
Capi. / Sales 2022 8,33x
Nbr of Employees 72
Free-Float 60,3%
Chart ANGION BIOMEDICA CORP.
Duration : Period :
Angion Biomedica Corp. Technical Analysis Chart | ANGN | US03476J1079 | MarketScreener
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 3,60 $
Average target price 26,67 $
Spread / Average Target 641%
Managers and Directors
Jay R. Venkatesan President, Chief Executive Officer & Director
Greg S. Curhan Chief Financial Officer
Itzhak D. Goldberg Executive Chairman & Chief Scientific Officer
John F. Neylan Chief Medical Officer & Senior Vice President
Jennifer J. Rhodes Secretary, Chief Compliance Office & Senior VP
Sector and Competitors
1st jan.Capi. (M$)
ANGION BIOMEDICA CORP.0.00%108
MODERNA, INC.188.59%122 239
LONZA GROUP AG25.98%57 878
IQVIA HOLDINGS INC.46.64%50 192
SEAGEN INC.-9.40%29 014
CELLTRION, INC.-40.67%24 745